OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Optimizing treatment for HER2-positive HR-positive breast cancer
Véronique Debien, Evandro de Azambuja, Martine Piccart
Cancer Treatment Reviews (2023) Vol. 115, pp. 102529-102529
Closed Access | Times Cited: 8

Showing 8 citing articles:

Molecular classification of hormone receptor-positive /HER2-positive breast cancer reveals potential neoadjuvant therapeutic strategies
Chao Liu, Lisha Sun, Nan Niu, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access

Hormone Receptor-Positive/HER2-Positive Breast Cancer: Hormone Therapy and Anti-HER2 Treatment: An Update on Treatment Strategies
Chiara Tommasi, Giulia Airò, Fabiana Pratticò, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 7, pp. 1873-1873
Open Access | Times Cited: 3

The Biological Roles and Clinical Applications of the PI3K/AKT Pathway in Targeted Therapy Resistance in HER2-Positive Breast Cancer: A Comprehensive Review
Hanyi Zhong, Ziling Zhou, Han Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13376-13376
Open Access | Times Cited: 2

Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer
Luis Velazquez‐Vega, Michael J. Rivera-Robles, Annelis O. Sánchez-Álvarez, et al.
Translational Oncology (2024) Vol. 44, pp. 101928-101928
Open Access | Times Cited: 1

Efficacy of everolimus‐based therapy in advanced triple‐positive breast cancer: Experience from three cancer centers in China
Yujing Tan, Hanfang Jiang, Fei Ma, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 34, pp. 3397-3405
Open Access | Times Cited: 2

Application and challenge of HER2DX genomic assay in HER2+ breast cancer treatment
Shujuan Ma, Yan Zhou, Dandan Ma, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4218-4235
Closed Access

Association of Granulocyte Colony-Stimulating Factor Treatment with Risk of Brain Metastasis in Advanced Stage Breast Cancer
Yun-Sheng Tai, John Leung, Shyh-Yau Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10756-10756
Open Access

Page 1

Scroll to top